Multiple Sclerosis
Conference Recap
Highlights on DMT Use in Progressive MS From CMSC 2021
New data on DMT use in progressive MS presented at CMSC 2021 — including results from the ACAPELLA and EXPAND trials, and the novel agent ATA188...
Conference Recap
Update on Multiple Sclerosis Comorbidities From CMSC 2021
Key updates from CMSC 2021 on prevalent multiple sclerosis comorbidities including prevalence of hypertension, elevated BMI, depression, and...
Conference Coverage
B-cell repletion is common with MS drug, but no symptom worsening
While “surprising,” these findings do not prove that B-cell repletion does not put someone at risk.
Conference Coverage
Brief, automated cognitive test may offer key advantages in MS
The automated NIH Toolbox Cognition Battery may be used as an alternative to other gold-standard measures which may cover limited domains or...
Conference Coverage
Specialty pharmacists may speed time to MS treatment
Because there currently is no established DMT selection algorithm, specialty pharmacists can assist in medication education and management.
Expert Interview
Radiologically Isolated Syndrome: A condition that often precedes an MS diagnosis in children
Expert Interview
Radiologically Isolated Syndrome: A condition that often precedes an MS diagnosis in children
Conference Recap
ECTRIMS 2021: Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis
Conference Coverage
Cannabis use common for MS-related spasticity
The new data reflect the latest patterns of use amid sweeping changes in recreational and medical marijuana laws.
Conference Coverage
New consensus guideline on clinical MRI use in MS
The updated protocol is beneficial in providing “simple, reasonable guidelines that can be easily acquired at almost any imaging location in the U...